Evidence map›Paper›PMID 37380539›Full record

Trial reportParkinsonism & related disorders2023

Long-term neuropsychological outcomes of deep brain stimulation in early-stage Parkinson's disease.

Mallory L Hacker, Michael G Tramontana, Kian Pazira, Jacqueline C Meystedt, Maxim Turchan, Kelly A Harper, Run Fan, Fei Ye, Thomas L Davis, Peter E Konrad and 1 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Parkinsonism & related disorders, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Observational
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Mallory L HackerDepartment of Neurology, Vanderbilt University Medical Center, United States. Electronic address: Mallory.Hacker@vumc.org.
Michael G TramontanaDepartment of Psychiatry, Vanderbilt University Medical Center, United States.
Kian PaziraDepartment of Neurology, Vanderbilt University Medical Center, United States.
Jacqueline C MeystedtDepartment of Neurology, Vanderbilt University Medical Center, United States.
Maxim TurchanDepartment of Neurology, Vanderbilt University Medical Center, United States.
Kelly A HarperDepartment of Neurology, Vanderbilt University Medical Center, United States.
Run FanDepartment of Biostatistics, Vanderbilt University Medical Center, United States.
Fei YeDepartment of Biostatistics, Vanderbilt University Medical Center, United States.
Thomas L DavisDepartment of Neurology, Vanderbilt University Medical Center, United States.
Peter E KonradDepartment of Neurosurgery, West Virginia University, United States.
David CharlesDepartment of Neurology, Vanderbilt University Medical Center, United States.

Funding

Vanderbilt Institute for Clinical and Translational Research (VICTR) -Identifying correlates of functional immunity in SARS-CoV-2 convalescent plasmaUL1TR002243 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Paul A. Harris, Wesley H Self · 2017 to 2026
$130.7M
West Virginia IDEA-CTRU54GM104942 · NIGMS · WEST VIRGINIA UNIVERSITY · PI JUDITH FEINBERG · 2012 to 2026
$81.0M
Investigating Long-Term Clinical Outcomes and Metabolic Network Activity Following Subthalamic Nucleus Deep Brain Stimulation in Early Stage Parkinson's DiseaseR21NS107877 · NINDS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI HACKER, MALLORY L. · 2018 to 2019
$425k
NCATS NIH HHS UL1 TR002243NIGMS NIH HHS U54 GM104942NINDS NIH HHS R21 NS107877
6 · The paper itself

Abstract

introductionThe pilot trial of deep brain stimulation (DBS) in early-stage Parkinson's disease (PD) randomized 30 patients (medication duration 0.5-4 years; without dyskinesia or motor fluctuations) to receive optimal drug therapy alone (early ODT) or subthalamic nucleus (STN) DBS plus ODT (early DBS + ODT). This study reports long-term neuropsychological outcomes from the early DBS pilot trial.

methodsThis is an extension of an earlier study that examined two-year neuropsychological outcomes in the pilot trial. The primary analysis was conducted on the five-year cohort (n = 28), and a secondary analysis was conducted on the 11-year cohort (n = 12). Linear mixed effects models for each analysis compared overall trend in outcomes for randomization groups. All subjects who completed the 11-year assessment were also pooled to evaluate long-term change from baseline.

resultsThere were no significant differences between groups in either the five- or 11-year analyses. Across all PD patients who completed the 11-year visit, there was significant decline in Stroop Color and Color-Word and Purdue Pegboard from baseline to 11 years.

conclusionsPrevious significant differences between the groups in phonemic verbal fluency and cognitive processing speed showing more decline for early DBS + ODT subjects one year after baseline diminished as PD progressed. No cognitive domains were worse for early DBS + ODT subjects compared to standard of care subjects. There were shared declines across all subjects on cognitive processing speed and motor control, likely reflecting disease progression. More study is needed to understand the long-term neuropsychological outcomes associated with early DBS in PD.

Indexed as

Deep Brain StimulationParkinson DiseaseSubthalamic NucleusDisease ProgressionHumansNeuropsychological TestsProcessing SpeedCognitionDeep brain stimulationParkinson's disease

Identifiers

PMID37380539
PMCPMC11232874

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.